Very nice report
When you talk about growth, this jumps out to me:
"~ 8K patients in first six months of 2023, versus ~ 10K patients through full year 2022"
That's an amazing growth and helping patients heal better.
The patients outcome will speak for PolyNovo products.
Remember that the sales are sticky - as a surgeon, if you are getting the desired results for the patients - you would continue to be an advocate for the product
GL All
Ann: 1H FY23 Results Presentation, page-7
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.47 |
Change
0.120(5.11%) |
Mkt cap ! $1.706B | |||
| Open | High | Low | Value | Volume |
| $2.38 | $2.52 | $2.38 | $6.169M | 2.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3613 | $2.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.48 | 38844 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |